Souza, R., Channick, R., Delcroix, M., Galiè, N., Ghofrani, H., Jansa, P., … Simonneau, G. (2013). Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan. Chest, 144(4), 879A-879A. https://doi.org/10.1378/chest.1701714

Souza, Rogùrio, Richard Channick, Marion Delcroix, Nazzareno Galiè, Hossein Ghofrani, Pavel Jansa, Franck-Olivier Le Brun, et al. “Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan.” Chest 144, no. 4 (October 2013): 879A-879A. https://doi.org/10.1378/chest.1701714.

Souza R, Channick R, Delcroix M, Galiè N, Ghofrani H, Jansa P, et al. Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan. Chest. 2013 Oct;144(4):879A-879A.

Souza, Rogùrio, et al. “Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan.” Chest, vol. 144, no. 4, Elsevier BV, Oct. 2013, pp. 879A-879A. Crossref, doi:10.1378/chest.1701714.

Souza R, Channick R, Delcroix M, Galiè N, Ghofrani H, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry B, Sitbon O, Torbicki A, Rubin L, Simonneau G. Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan. Chest. Elsevier BV; 2013 Oct;144(4):879A-879A.